SHMY·July 6, 2026·restatement
Synergy Empire Files Amended 8-K to Restate Details of Meluha Therapeutics Acquisition
Synergy Empire Limited filed an amendment to its original July 2024 current report, providing a greatly expanded description of its acquisition of Malaysian biopharmaceutical company Meluha Therapeutics Berhad. The filing restates the deal terms and adds extensive new detail on Meluha's business, products, industry, and risk factors.